Source: International Congress 2014 – Latest insights in airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Gauvreau, L. P. Boulet, J. M. FitzGerald, D. Cockcroft, B. Davis, R. Leigh, M. Tanaka, J. Fourre, M. Tanaka, T. Nabata, P. O'Byrne (Hamilton, Quebec, Vancouver, Saskatoon, Calgary, Canada; Osaka, Japan). LATE-BREAKING ABSTRACT: Effects of a dual CysLT1/2 antagonist, ONO-6950, on allergen-induced airway responses in subjects with mild allergic asthma.. Eur Respir J 2014; 44: Suppl. 58, 2813

Member's Comments

No comment yet.

Related content which might interest you: LATE-BREAKING ABSTRACT: Attenuation of allergen-induced asthmatic responses by inhaled GATA-3 specific DNAzyme Source: International Congress 2014 – Latest insights in airway diseases Year: 2014 LATE-BREAKING ABSTRACT: Inhibition of TRPA1 reduces airway inflammation and airway hyper-responsiveness in a murine model of allergic rhinitis Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease Year: 2016 Species comparison of interleukin-13 induced airway hyperreactivity as model for allergic asthma Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 A novel inhaled PI3Kδ inhibitor, LAS194223 reduces allergen-induced airway inflammation in rat Source: International Congress 2014 – New drugs for asthma, COPD and pulmonary fibrosis Year: 2014 Bronchodilator effect of a novel inhaled dual PDE3/4 inhibitor, RPL554, in mild allergic asthma & rhinitis Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics Year: 2013 The effect of trehalose for the allergen-induced airway hyperresponsiveness and airway inflamation in mice Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 LATE-BREAKING ABSTRACT: The CCR4 Antagonist CCX6239 for the treatment of allergic airways disease Source: Annual Congress 2013 –Treatment of asthma Year: 2013 LATE-BREAKING ABSTRACT: Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting the allergen-induced early asthmatic response Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment Year: 2014 Airway hyperresponsiveness (AHR) of small airways assessed by impulse oscillation (IOS) in adult asthma Source: International Congress 2015 – Asthma mechanisms and management Year: 2015 Beta2 adrenergic agonist attenuates house dust mite-induced allergic airway inflammation in mice Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation Year: 2014 LATE-BREAKING ABSTRACT: IL-5-induced airways eosinophilia as a negative regulator of TLR7 expression may impair the interferon response to rhinovirus in allergic airways Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment Year: 2014 New inhaled JAK inhibitor LAS194046 inhibits allergen-induced airway inflammation in Brown Norway rats Source: International Congress 2014 – New drugs for asthma, COPD and pulmonary fibrosis Year: 2014 Adult asthma patients reporting exacerbations triggered by upper airway infection have increased total IgE and sensitization to HDM Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014 The effect of the inhaled PDE4 inhibitor CHF6001 on allergen-induced inflammation in asthmatics Source: International Congress 2014 – Asthma and COPD management Year: 2014 Dose-dependent differential effects of thrombin in allergic bronchial asthma Source: Annual Congress 2013 –Murine models of lung immunology Year: 2013 Effect of roflumilast on airway remodeling in a murine model of chronic asthma Source: International Congress 2015 – New models for treating airway diseases Year: 2015 Improved effects of aerosol-type fluticasone propionate/formoterol combination on residual asthmatic inflammation in distal airways of patients with moderate asthma Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Pharmacogenetics in severity of bronchial hyperresponsiveness in asthma Source: Annual Congress 2013 –Genetic factors in airway development and disease Year: 2013 Can forced oscillation technique parameters predict airway hyperresponsiveness to histamine? Source: International Congress 2014 – Asthma: clinical problems Year: 2014 Changes in symptoms, respiratory function, airway inflammation, and airway hyperresponsiveness over 10 year of inhaled corticosteroid therapy in adult asthma patients Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015